Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to this agreement, the Company…
valeo
Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
There’s nothing more terrifying than watching a loved one pause, clutch their throat and start gasping for air. The first time it happens provokes the mad scramble, as she…
Valeo Pharma’s (VPH.C) low molecular weight heparin (LMWH) drug, Redesca and Redesca HP, is now eligible for public reimbursement in seven provinces and territories across Canada, as well as…
Valeo Pharma (VPH.C) announced that they have begun commercialization of their Enerzair Breezhaler and Atectura Breezhaler following the shipment of the product across Canada and the deployment of their…
Valeo Pharma (VPH.C) announced they have entered into a Product Listing Agreement (PLA) with the Executive Officer of the Ontario Public Drug Program for the listing of Redesca and…
Valeo Pharma (VPH.C) announced they have begun shipments across Canada of Redesca and Redesca HP, their low molecular weight heparin (LMWH) biosimilar. Valeo has licensed Redesca from Shenzhen Techdow…
Valeo Pharma (VPH.C) has announced a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units a a price of $1000 per unit for maximum gross proceeds of…
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled with various issues such…